Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Follow up of Patients Enrolled in the Pivotal Study of Betaseron® (Interferon Beta 1b) in Relapsing-remitting Multiple Sclerosis

NCT00206635 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00206635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00206635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Follow up of Patients Enrolled in the Pivotal Study of Betaseron® (Interferon Beta 1b) in Relapsing-remitting Multiple Sclerosis
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
January 31, 2005
Completion date
December 31, 2005
Enrollment
432 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis